Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Singapore eDevelopment Limited
Singapore eDevelopment Limited
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
N4 Pharma and SRI to target and treat previously unreachable human cells
The companies will collaborate to perform research to conjugate SRI’s MGS system to Nuvec to increase intracellular delivery to specific target cells.
Berry Global invests to increase production capacity for healthcare products
Berry Global Group has invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three of its European sites
Innovation in generics: increased efficiency through peptide API synthesis expertise
Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Ingredients
Impact Biomedical initiates research programme to solve the patent cliff
The primary cause of the patent crisis is that most techniques for modifying natural molecules to pharmaceutical grade products are essentially 'played out'
Research & Development
Equivir shows prophylactic COVID-19 results in independent testing
Impact Biomedical has announced in vitro success with Equivir and 3F Biofragrance against COVID-19 in independent laboratory testing
Ingredients
Impact BioMedical looks at compounds that block coronavirus mechanisms
The coronavirus has presented a unique challenge to exploit a 'hand shake' docking site to human cellular membranes that is atypical of Influenza and Rhinovirus
Research & Development
Singapore eDevelopment researches universal drug platform
Six month target for validating lab data, twelve month target for completion of platform
Subscribe now